MANIPULATION OF CYTOKINE NETWORKS IN TRANSPLANTATION
NITRIC OXIDE SYNTHASE ACTIVITY IN RENAL ISCHEMIA-REPERFUSION INJURY IN THE RAT
TREATMENT OF EXPERIMENTAL ISCHEMIA/REPERFUSION INJURY WITH S-ADENOSYLMETHIONINE
SUCCESSFUL LONG-TERM XENOPERFUSION OF THE PIG LIVER
MONITORING ENGRAFTMENT OF TRANSPLANTED HEPATOCYTES IN RECIPIENT LIVER WITH 5-BROMO-2′-DEOXYURIDINE
NEPHRON MASS MODULATES THE HEMODYNAMIC, CELLULAR, AND MOLECULAR RESPONSE OF THE RAT RENAL ALLOGRAFT1
CYCLOSPORINE REDUCES DEVELOPMENT OF OBLITERATIVE BRONCHIOLITIS IN A MURINE HETEROTOPIC AIRWAY MODEL
RAPAMYCIN INHIBITS DEVELOPMENT OF OBLITERATIVE AIRWAY DISEASE IN A MURINE HETEROTOPIC AIRWAY TRANSPLANT MODEL1
VALUE OF AN EXTENDED MONOETHYLGLYCINEXYLIDIDE FORMATION TEST AND OTHER DYNAMIC LIVER FUNCTION TESTS IN LIVER TRANSPLANT DONORS
IDENTIFICATION OF PATIENTS AT HIGH RISK OF GRAFT LOSS BY PRE- AND POSTTRANSPLANT MONITORING OF ANTI-HLA CLASS I IgG ANTIBODIES BY ENZYME-LINKED IMMUNOSORBENT ASSAY
DIAGNOSTIC CONTRIBUTION OF RENAL ALLOGRAFT BIOPSIES AT VARIOUS INTERVALS AFTER TRANSPLANTATION
FLOW CYTOMETRY CROSS-MATCH
RENAL TRANSPLANTATION IN CHILDREN LESS THAN TWO YEARS OLD1
HEPATOCYTE TRANSPLANTATION AS A BRIDGE TO ORTHOTOPIC LIVER TRANSPLANTATION IN TERMINAL LIVER FAILURE
BIOLOGICAL EFFECTS AND FATE OF A SOLUBLE, DIMERIC, 80-kDa TUMOR NECROSIS FACTOR RECEPTOR IN RENAL TRANSPLANT RECIPIENTS WHO RECEIVE OKT3 THERAPY1
RS-61443 PREVENTS MICROVASCULAR REJECTION OF PANCREATIC ISLET XENOGRAFTS
APOPTOSIS INDUCTION IN HUMAN PERIPHERAL BLOOD T LYMPHOCYTES BY HIGH-DOSE STEROID THERAPY
HUMAN SERUM REACTIVITY TO PORCINE ENDOTHELIAL CELLS AFTER ANTISENSE-MEDIATED DOWN-REGULATION OF GpIIIa EXPRESSION1
HYPERACUTE LUNG REJECTION IN A PIG-TO-HUMAN TRANSPLANT MODEL
CONTINUOUS INTRAVENOUS INFUSION OF EPOPROSTENOL FOR THE TREATMENT OF PORTOPULMONARY HYPERTENSION1
INTRAOPERATIVE PLACEMENT OF A WALLSTENT FOR PORTAL VEIN STENOSIS AND THROMBOSIS AFTER LIVER TRANSPLANTATION
ANTIBODY TO THE HOST CELLULAR GENE-DERIVED EPITOPE GOR-1 IN LIVER TRANSPLANT RECIPIENTS WITH HEPATITIS C VIRUS INFECTION1
ENHANCED LIVER CALPAIN PROTEASE ACTIVITY IS A RISK FACTOR FOR DYSFUNCTION OF HUMAN LIVER ALLOGRAFTS1,2
CONSECUTIVE SUCCESSFUL PREGNANCIES IN A COMBINED LIVER AND KIDNEY TRANSPLANT RECIPIENT WITH TYPE 1 PRIMARY HYPEROXALURIA
QUANTITATION OF SOLUBLE HLA ANTIGENS IN HUMAN SERUM
ERRATUM